| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1537-2995.2003.00443.X |
| P698 | PubMed publication ID | 12823755 |
| P2093 | author name string | Neil Blumberg | |
| Joanna M Heal | |||
| Kelly F Gettings | |||
| P2860 | cites work | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 |
| M-1/M-2 macrophages and the Th1/Th2 paradigm | Q28145893 | ||
| Th1 and Th2 cells | Q34118616 | ||
| Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? | Q34164463 | ||
| Th1 and Th2 in human diseases | Q41114655 | ||
| The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
| A central role of CD40 ligand in the regulation of CD4+ T-cell responses | Q41149910 | ||
| Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion | Q43662394 | ||
| Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery | Q45258025 | ||
| Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. | Q52247763 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 945-952 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization | |
| P478 | volume | 43 |
| Q104064741 | A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients |
| Q53618730 | Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. |
| Q50770424 | Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. |
| Q38049189 | Challenges of alloimmunization in patients with haemoglobinopathies |
| Q90783927 | Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience |
| Q50758168 | Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion. |
| Q26784256 | Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility |
| Q50204408 | Determinants of red blood cell alloantibody detection duration: analysis of multiply alloimmunized patients supports peritransfusion factors |
| Q34792041 | Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models. |
| Q35507212 | Frequency and specificity of red blood cell alloimmunization in chilean transfused patients |
| Q41085850 | Frequency and specificity of red cell antibodies in thalassemia patients in Albania |
| Q46702086 | Genomewide association study of HLA alloimmunization in previously pregnant blood donors |
| Q39036189 | High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients |
| Q88720568 | Indications for red cell transfusions in pediatric patients |
| Q35924467 | Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products |
| Q33361167 | Optimizing platelet transfusion therapy |
| Q50774708 | Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients. |
| Q35763368 | Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd |
| Q50721622 | Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. |
| Q37037139 | Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients |
| Q36569071 | Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan. |
| Q52640370 | Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods. |
| Q34569009 | Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review |
| Q44539191 | Red cell alloimmunization in a diverse population of transfused patients with thalassaemia |
| Q36262771 | Red cell alloimmunization in multitransfused patients and multiparous women |
| Q91384477 | Red cell alloimmunization in transfusion-dependent and transfusion-independent beta thalassemia: A review from the Eastern Mediterranean Region (EMRO) |
| Q34791984 | Responder individuality in red blood cell alloimmunization |
| Q38934537 | Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells |
| Q40611312 | Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation |
| Q51500449 | Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mia ' records decreases transfusion reaction rates in Taiwan. |
| Q38855951 | Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt |
| Q79823833 | The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery |
| Q50449455 | Transforming growth factor-β released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation. |
| Q38156241 | Transfusion immunomodulation from a clinical perspective: an update |
| Q55073506 | Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman. |
| Q50471724 | Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital. |
| Q34824419 | Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens |
| Q40528779 | Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy |
| Q91942080 | Transfusion-related red blood cell alloantibodies: induction and consequences |
| Q39027819 | Understanding red blood cell alloimmunization triggers. |
| Q36207276 | What would Karl Landsteiner do? The ABO blood group and stem cell transplantation |
Search more.